-transparent.png){kind=logo}
The authors report on a new case of severe hypercalcaemia induced by prolonged oral treatment with high doses of vitamin D2. (6 mg/day for 9 months). Blood calcium level did not return to normal until 6 months after the drug was discontinued. The plasma concentration of 25 (OH) D was more than three times the normal value and remained very high throughout the observation period. The plasma concentration of 24, 25 (OH)2 D was slightly raised during treatment but became normal after 15 days, while that of 1,25 (OH)2 D, the active form of vitamin D, remained normal throughout, suggesting that the pathogenesis of vitamin D-induced hypercalcaemia is probably complex.
Related Publications
A Ulmann, and
A Bourdeau, and
M Lair, and
C Bader
January 1977,
Przeglad lekarski,
A Ulmann, and
A Bourdeau, and
M Lair, and
C Bader
March 1982,
Nihon Naibunpi Gakkai zasshi,
A Ulmann, and
A Bourdeau, and
M Lair, and
C Bader
June 1987,
The American journal of medicine,
A Ulmann, and
A Bourdeau, and
M Lair, and
C Bader
January 1976,
Postepy biochemii,
A Ulmann, and
A Bourdeau, and
M Lair, and
C Bader
October 1978,
Nihon rinsho. Japanese journal of clinical medicine,
A Ulmann, and
A Bourdeau, and
M Lair, and
C Bader
March 1981,
Archives francaises de pediatrie,
A Ulmann, and
A Bourdeau, and
M Lair, and
C Bader
March 1985,
Archives francaises de pediatrie,
A Ulmann, and
A Bourdeau, and
M Lair, and
C Bader
November 1979,
Casopis lekaru ceskych,
A Ulmann, and
A Bourdeau, and
M Lair, and
C Bader
January 1946,
Connecticut medicine,
A Ulmann, and
A Bourdeau, and
M Lair, and
C Bader
January 2022,
American journal of therapeutics,
